Generation Bio Inc. (GBIO): Price and Financial Metrics Recent IPO


Generation Bio Inc. (GBIO) Recent IPO

Today's Latest Price: $37.79 USD

2.51 (7.11%)

Updated Nov 24 4:00pm

Add GBIO to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

GBIO Stock Price Chart Interactive Chart >

Price chart for GBIO

GBIO Price/Volume Stats

Current price $37.79 52-week high $38.00
Prev. close $35.28 52-week low $17.00
Day low $35.16 Volume 97,900
Day high $38.00 Avg. volume 173,685
50-day MA $28.19 Dividend yield N/A
200-day MA $0.00 Market Cap 1.76B

Generation Bio Inc. (GBIO) Company Bio


Generation Bio Co. is a genetic medicines company focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.


GBIO Latest News Stream


Event/Time News Detail
Loading, please wait...

GBIO Latest Social Stream


Loading social stream, please wait...

View Full GBIO Social Stream

Latest GBIO News From Around the Web

Below are the latest news stories about Generation Bio Co that investors may wish to consider to help them evaluate GBIO as an investment opportunity.

Generation Bio names new finance chief

Generation Bio (GBIO) appoints Matthew Norkunas, as the new chief financial officer, of the company. Dr. Norkunas most recently served as CFO at SomaLogic, a Colorado-based biotech that uses a proprietary protein scan to evaluate health and assess disease risk....

Seeking Alpha | July 22, 2020

Generation Bio prices IPO at $19

Generation Bio (GBIO) has priced its IPO of 10,526,316 common shares at $19.00/share, for expected gross proceeds of ~$200M.Underwriters' over-allotment is an additional 1,578,947 shares. Trading kicks off today.Closing date is June 16....

Seeking Alpha | June 12, 2020

Read More 'GBIO' Stories Here

GBIO Price Returns

1-mo 72.09%
3-mo 46.59%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7731 seconds.